HTA46 Outcomes of Benefit Assessments of Orphan Drugs Without Orphan Designation in Germany

Abstract

Authors

L Frick Z Qiu M Schönermark

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×